Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gain Therapeutics Inc
(NQ:
GANX
)
2.630
-0.060 (-2.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gain Therapeutics Inc
< Previous
1
2
3
4
Next >
Expert Ratings for Gain Therapeutics
December 09, 2022
Via
Benzinga
Analyst Ratings for Gain Therapeutics
December 09, 2022
Via
Benzinga
Medtronic To $85? Plus Oppenheimer Slashes PT On This Stock By 67%
November 25, 2022
Via
Benzinga
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
November 14, 2022
BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at...
Via
Benzinga
AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday
November 14, 2022
Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at...
Via
Benzinga
Gain Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Business Update
November 10, 2022
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics Touts Additional Encouraging Preclinical Data For Lead Parkinson's Program
September 26, 2022
Via
Benzinga
Gain Therapeutics: Q2 Earnings Insights
August 08, 2022
Gain Therapeutics (NASDAQ:GANX) reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: Gain Therapeutics Q1 Earnings
May 16, 2022
Gain Therapeutics (NASDAQ:GANX) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
August 19, 2022
Upgrades
Via
Benzinga
Apple To $185? Here Are 5 Other Price Target Changes For Friday
August 19, 2022
Keybanc raised the price target on Apple Inc. (NASDAQ: AAPL) from $177 to $185. However, Keybanc analyst Brandon Nispel maintained the stock with an Overweight. Apple shares fell 0.9% to $172.63 in...
Via
Benzinga
Gain Therapeutics: Reasons For Optimism
August 09, 2022
In biotechnology, potential rules. And in Gain's case, the potential to not just treat but functionally cure at least some forms of Parkinson's Disease is strong enough to weather early-stage...
Via
Talk Markets
Aggregate Insider Buying Remains Elevated For A Third Week $AMH
May 23, 2022
In another challenging week for the markets where the Nasdaq dropped nearly 4%, insiders once again significantly stepped up their insider purchases for a third week in a row. We saw an increase across...
Via
Benzinga
Gain Therapeutics Shares Skyrocket After Preclinical Data From Parkinson's Program
April 12, 2022
Gain Therapeutics Inc (NASDAQ: GANX) has
Via
Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 10, 2022
Good morning! We're starting off another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
55 Stocks Moving In Friday's Mid-Day Session
May 06, 2022
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
Via
Benzinga
92 Biggest Movers From Friday
May 09, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
March 29, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 15, 2022
Gainers Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 92.3% to $44.04 during Tuesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
February 01, 2022
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares climbed 30.7% to $4.4095 after the company provided an update on patient recruitment for the Phase III study for the treatment of...
Via
Benzinga
52 Biggest Movers From Yesterday
February 02, 2022
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969. Synaptogenix, Inc. (NASDAQ: SNPX) climbed 29.4% to close at $10.09. Synaptogenix...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 12, 2022
On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a...
Via
Benzinga
52 Weeks High And Low Article
January 11, 2022
Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x...
Via
Benzinga
Gain Therapeutics Stock Surges On Positive Preclinical Readout For Neurodegenerative Disease Drugs
November 10, 2021
Gain Therapeutics, Inc. (NASDAQ: GANX) shares were trading higher Wednesday after the company presented positive data on two of its lead compounds. What Happened: Bethesda,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021
November 03, 2021
Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE:
Via
Benzinga
Gain Therapeutics' SEE-Tx™ Platform Shows Increasing Evidence in Treating Diseases Caused by Protein Misfolding
October 12, 2021
Image by National Cancer Institute on Unsplash Medical and technological advancements are extending our lifespan. Unfortunately, as human life expectancy rises, so does the risk...
Via
Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.